Brainchip shares dive after CEO stands down

NEW YORK: Brainchip, the billion dollar company promising to build computer chips that ... read more

Analysts call $310 CSL target price in new report

SYDNEY: Biotech company CSL was upgraded to ‘buy’ by analysts at Citi Group ... read more

Genesis completes takeover of failed dental group Smiles Inclusive

BURLEIGH HEADS: Genesis Capital has taken control of failed Gold Coast dental group ... read more

Private hospitals prepping for COVID normal operating conditions

SYDNEY: Australia’s private hospital operators are preparing for “COVID normal” to bring surgeries ... read more